Running Oak Capital LLC Purchases 6,446 Shares of IQVIA Holdings Inc. (NYSE:IQV)

Running Oak Capital LLC grew its position in IQVIA Holdings Inc. (NYSE:IQV) by 20.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 38,475 shares of the medical research company’s stock after acquiring an additional 6,446 shares during the period. Running Oak Capital LLC’s holdings in IQVIA were worth $8,902,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Commonwealth Equity Services LLC lifted its holdings in IQVIA by 3.6% during the 3rd quarter. Commonwealth Equity Services LLC now owns 20,753 shares of the medical research company’s stock valued at $4,083,000 after buying an additional 726 shares in the last quarter. Pinnacle Associates Ltd. grew its position in IQVIA by 65.6% during the 3rd quarter. Pinnacle Associates Ltd. now owns 1,678 shares of the medical research company’s stock worth $330,000 after purchasing an additional 665 shares during the last quarter. Raymond James & Associates grew its position in IQVIA by 4.4% during the 3rd quarter. Raymond James & Associates now owns 832,515 shares of the medical research company’s stock worth $163,797,000 after purchasing an additional 35,448 shares during the last quarter. Raymond James Financial Services Advisors Inc. grew its position in IQVIA by 6.1% during the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 532,369 shares of the medical research company’s stock worth $104,744,000 after purchasing an additional 30,403 shares during the last quarter. Finally, Stratos Wealth Partners LTD. grew its position in IQVIA by 6.4% during the 3rd quarter. Stratos Wealth Partners LTD. now owns 6,739 shares of the medical research company’s stock worth $1,326,000 after purchasing an additional 404 shares during the last quarter. Institutional investors own 89.62% of the company’s stock.

Insider Buying and Selling

In other news, insider Kevin C. Knightly sold 8,607 shares of the stock in a transaction on Wednesday, February 28th. The stock was sold at an average price of $250.17, for a total value of $2,153,213.19. Following the completion of the transaction, the insider now owns 5,251 shares of the company’s stock, valued at $1,313,642.67. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other IQVIA news, insider Kevin C. Knightly sold 8,607 shares of the company’s stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $250.17, for a total value of $2,153,213.19. Following the transaction, the insider now directly owns 5,251 shares of the company’s stock, valued at approximately $1,313,642.67. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Ari Bousbib sold 31,678 shares of the stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $250.53, for a total value of $7,936,289.34. Following the transaction, the insider now directly owns 796,752 shares in the company, valued at approximately $199,610,278.56. The disclosure for this sale can be found here. Insiders sold a total of 41,285 shares of company stock worth $10,331,003 in the last three months. 1.60% of the stock is owned by insiders.

IQVIA Price Performance

IQVIA stock traded down $10.80 during midday trading on Thursday, reaching $222.14. 1,697,675 shares of the company were exchanged, compared to its average volume of 973,070. The company has a debt-to-equity ratio of 2.12, a quick ratio of 0.86 and a current ratio of 0.86. The company has a market capitalization of $40.32 billion, a price-to-earnings ratio of 31.95, a P/E/G ratio of 2.24 and a beta of 1.52. The firm’s 50-day simple moving average is $245.07 and its 200-day simple moving average is $223.85. IQVIA Holdings Inc. has a 1 year low of $167.42 and a 1 year high of $261.73.

IQVIA (NYSE:IQV) last released its quarterly earnings results on Wednesday, February 14th. The medical research company reported $2.84 EPS for the quarter, topping the consensus estimate of $2.82 by $0.02. IQVIA had a return on equity of 29.32% and a net margin of 9.06%. The firm had revenue of $3.87 billion for the quarter, compared to analyst estimates of $3.80 billion. During the same period in the previous year, the company posted $2.54 EPS. IQVIA’s revenue for the quarter was up 3.5% on a year-over-year basis. On average, analysts anticipate that IQVIA Holdings Inc. will post 10.12 EPS for the current year.

Analyst Ratings Changes

Several analysts have commented on the stock. StockNews.com upgraded shares of IQVIA from a “hold” rating to a “buy” rating in a research note on Friday, February 16th. Barclays boosted their target price on shares of IQVIA from $260.00 to $265.00 and gave the company an “overweight” rating in a research note on Thursday, February 15th. BTIG Research began coverage on shares of IQVIA in a report on Tuesday, February 13th. They issued a “buy” rating and a $285.00 price target for the company. Truist Financial boosted their price target on shares of IQVIA from $286.00 to $297.00 and gave the stock a “buy” rating in a report on Tuesday, February 27th. Finally, SVB Leerink began coverage on shares of IQVIA in a report on Monday, February 26th. They issued an “outperform” rating and a $290.00 price target for the company. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, IQVIA currently has a consensus rating of “Moderate Buy” and an average price target of $259.43.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.